Delivery Order SPE2DB22D1017-SPE2DB25FG2MW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count bottles) valued at $2,559.11, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units) under a firm fixed-price contract. The order, valued at $6,858.34, was competitively awarded without set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,066.33 with a firm fixed price structure. The award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order executed under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $5,802.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $2,305.86. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The award supports pharmaceutical supply to federal military and healthcare systems, with performance based in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,591.48 and a firm fixed price contract type. The award, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG2MWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $8,552.45 under a firm fixed-price, non-competitive delivery order contract. The award was executed on May 13, 2025, with an ultimate completion date of May 14, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for Department of Defense medical supply chain needs. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, holds a critical role in federal medical procurement as a prime vendor for military and veteran healthcare systems. The company's DLA contract portfolio demonstrates extensive capability in delivering a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally. This particular delivery order represents a routine transaction within the company's ongoing pharmaceutical supply operations to the Defense Health Agency and other federal healthcare customers, consistent with its established track record of fulfilling federal medical supply requirements through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/13/25 |